title: Uterine-conceptus interactions and reproductive failure in cattle.
abstract: The dialogue between trophectoderm cells of the conceptus and epithelial cells of the endometrium is critical to CL maintenance and embryo survival. The signal transduction mechanisms by which bovine interferon (IFN)-tau regulates cyclooxygenase (COX)-2 expression and secretion of prostaglandin F2alpha (PGF2alpha) in bovine endometrial (BEND) cells is examined. Stimulation of Protein Kinase C with a phorbol ester (phorbol 12, 13 dibutyrate [PDBu]) activates COX-2 gene expression and PGF2alpha secretion via the mitogen-activated protein kinase (MAPK) pathway. Interferon-tau attenuates PDBu activation of PGF2alpha secretion, but this inhibitory effect appears to be independent of the MAPK pathway. Embryonic IFN-tau, acting through a Type I IFN receptor, activates the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway resulting in activation or repression of interferon-stimulated genes. Experimental evidence is provided that IFN-tau regulation of STATs regulates gene expression of COX-2 in a manner that decreases secretion of PGF2alpha. Maternal regulation of the antiluteolytic pathway is discussed relative to the ability of the polyunsaturated fatty acid, eicosapentaenoic (EPA), to decrease endometrial secretion of PGF2alpha and progesterone to increase both conceptus development and IFN-tau secretion.
authors.affiliation: Department of Animal Sciences, University of Florida, Gainesville 32610, USA.
authors.forename: W W
authors.initials: WW
authors.lastname: Thatcher
authors.forename: A
authors.initials: A
authors.lastname: Guzeloglu
authors.forename: R
authors.initials: R
authors.lastname: Mattos
authors.forename: M
authors.initials: M
authors.lastname: Binelli
authors.forename: T R
authors.initials: TR
authors.lastname: Hansen
authors.forename: J K
authors.initials: JK
authors.lastname: Pru
mesh_terms: D000818:Animals; D002417:Cattle; D003340:Corpus Luteum Maintenance / Q000502:physiology; D051546:Cyclooxygenase 2; D015237:Dinoprost / Q000378:metabolism*; D004717:Endometrium / Q000166:cytology / Q000201:enzymology / Q000502:physiology*; D004847:Epithelial Cells / Q000166:cytology / Q000201:enzymology / Q000502:physiology; D005231:Fatty Acids, Unsaturated / Q000502:physiology; D005260:Female; D007370:Interferon Type I / Q000502:physiology*; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism*; D053613:Janus Kinase 1; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000502:physiology*; D011374:Progesterone / Q000502:physiology; D011451:Prostaglandin-Endoperoxide Synthases / Q000235:genetics / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D015398:Signal Transduction; D014158:Transcription, Genetic / Q000502:physiology; D014327:Trophoblasts / Q000166:cytology / Q000502:physiology*
chemical_list: D005231:Fatty Acids, Unsaturated; D007370:Interferon Type I; D007527:Isoenzymes; D011257:Pregnancy Proteins; C020947:interferon tau; D011374:Progesterone; D015237:Dinoprost; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases; D011505:Protein-Tyrosine Kinases; D053613:Janus Kinase 1; D020928:Mitogen-Activated Protein Kinases